Understanding and preventing Alzheimer's disease and related disorders
University of Kansas Alzheimer's Disease Research Center (KU ADRC)
The University of Kansas Alzheimer's Disease Research Center is looking for ways to help prevent and treat Alzheimer's disease by studying how our bodies use energy and how lifestyle changes can make a difference, so if you’re interested in being part of this important research, you could gain access to new findings and helpful programs.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project ID | NIH-10873093 on NIH RePORTER |
What this research studies
The University of Kansas Alzheimer's Disease Research Center (KU ADRC) focuses on advancing research related to Alzheimer's Disease and Related Disorders (ADRD). This research involves exploring the role of metabolism, mitochondrial function, and lifestyle modifications in the prevention and treatment of Alzheimer's disease. By integrating basic science with clinical applications, the center aims to uncover new insights into the disease mechanisms and develop effective interventions. Patients may benefit from participation in lifestyle intervention studies and access to cutting-edge research findings.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals at risk for Alzheimer's disease, those with early symptoms, or caregivers of affected individuals.
Not a fit: Patients with advanced Alzheimer's disease or those not residing in the study's geographic area may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention strategies and treatments for Alzheimer's disease and related dementias.
How similar studies have performed: Previous research has shown promising results in understanding the metabolic aspects of Alzheimer's disease, indicating that this approach has potential for significant breakthroughs.
Where this research is happening
Kansas City, United States
- University of Kansas Medical Center — Kansas City, United States (Active)
Researchers
- Principal investigator: Swerdlow, Russell H. — University of Kansas Medical Center
- Study coordinator: Swerdlow, Russell H.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.